Related references
Note: Only part of the references are listed.Identification of TP53 mutations in circulating tumour DNA in high grade serous ovarian carcinoma using next generation sequencing technologies
Leslie Calapre et al.
SCIENTIFIC REPORTS (2023)
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences
Tenna Vesterman Henriksen et al.
CLINICAL CANCER RESEARCH (2022)
A clinician's handbook for using ctDNA throughout the patient journey
Samantha O. Hasenleithner et al.
MOLECULAR CANCER (2022)
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Jeanne Tie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Prognostic significance of postsurgery circulating tumorDNAin nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies
Jeanne Tie et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Aparna R. Parikh et al.
CLINICAL CANCER RESEARCH (2021)
Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
Gong Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
Jeanne Tie et al.
PLOS MEDICINE (2021)
MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer
Shelize Khakoo et al.
CLINICAL CANCER RESEARCH (2020)
The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA
Tenna V. Henriksen et al.
MOLECULAR ONCOLOGY (2020)
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Jeanne Tie et al.
GUT (2019)
Clonal hematopoiesis of indeterminate potential (CHIP) mutations in solid tumor malignancies.
Madison Conces et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert et al.
JAMA ONCOLOGY (2019)
RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer
Erik J. van Helden et al.
MOLECULAR ONCOLOGY (2019)
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
N. Tarazona et al.
ANNALS OF ONCOLOGY (2019)
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Jeanne Tie et al.
JAMA ONCOLOGY (2019)
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Lone V. Scholer et al.
CLINICAL CANCER RESEARCH (2017)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era
Dordi Lea et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Early Detection of Colorectal Cancer Recurrence in Patients Undergoing Surgery with Curative Intent: Current Status and Challenges
Patrick. E. Young et al.
JOURNAL OF CANCER (2014)